Efficacy and safety of apixaban versus warfarin in patients with atrial fibrillation and a history of cancer: insights from the ARISTOTLE Trial. Am J Med. 2017;130:1440 1448.e1. 649. Shah S, Norby FL, Datta YH, Lutsey PL, MacLehose RF, Chen LY, Alonso A. Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation. Blood Adv. 2018;2:200 209. 650. Yang P, Zhu D, Xu X, Shen W, Wang C, Jiang Y, Xu G, Wu Q. Efficacy and safety of oral anticoagulants in atrial fibrillation patients with can- cer: a network meta-analysis. Heart Fail Rev. 2020;25:823 831. doi: 651. Dardiotis E, Aloizou AM, Markoula S, Siokas V, Tsarouhas K, Tzanakakis G, Libra M, Kyritsis AP, Brotis AG, Aschner M, et al. Cancer-associated stroke: pathophysiology, detection and management (review). Int J Oncol. 652. Adams HP Jr. Cancer and cerebrovascular disease. Curr Neurol Neurosci Options Neurol. 2002;4:417 425. doi: 10.1007/s11940-002-0009-1 654. Navi BB, Marshall RS, Bobrow D, Singer S, Stone JB, DeSancho MT, DeAngelis LM. Enoxaparin vs aspirin in patients with cancer and isch- emic stroke: the TEACH pilot randomized clinical trial. JAMA Neurol. 655. Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, Abboud M, Gallagher D, Kutlar A, Nichols FT, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998;339:5 11. doi: 656. Russell MO, Goldberg HI, Hodson A, Kim HC, Halus J, Reivich M, Schwartz E. Effect of transfusion therapy on arteriographic abnormalities and on re- currence of stroke in sickle cell disease. Blood. 1984;63:162 169. 657. 